• 1. Alt-proteins: A promising future
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Aminopiperidines

Professional Introduction to Compound with CAS No. 71335-68-7 and Product Name: 1-Piperidinyloxy, 4-(dimethylamino)-2,2,6,6-tetramethyl

The compound with the CAS number 71335-68-7 and the product name 1-Piperidinyloxy, 4-(dimethylamino)-2,2,6,6-tetramethyl represents a fascinating molecule with significant potential in the field of chemical biology and pharmaceutical research. This compound belongs to a class of nitrogen-containing heterocycles that have garnered considerable attention due to their diverse biological activities and structural versatility. The presence of multiple functional groups, including a piperidinyloxy moiety and a dimethylamino substituent, combined with a highly stable tetramethyl group at the central carbon atom, makes this molecule a promising candidate for further exploration in drug discovery and molecular design.

In recent years, the development of novel therapeutic agents has been heavily influenced by the discovery and optimization of small molecules that can modulate biological pathways with high specificity and efficacy. The structure of 1-Piperidinyloxy, 4-(dimethylamino)-2,2,6,6-tetramethyl is particularly intriguing because it incorporates elements that are known to enhance binding affinity and metabolic stability. The tetramethyl substitution at the central carbon atom not only imparts rigidity to the molecule but also improves its solubility in various solvents, making it suitable for both in vitro and in vivo studies.

One of the most compelling aspects of this compound is its potential as a scaffold for drug development. The piperidinyloxy group is a well-known pharmacophore that has been extensively studied for its role in various biological processes. It has been shown to interact with a wide range of targets, including enzymes and receptors involved in neurotransmission, inflammation, and cancer. The dimethylamino group further enhances the compound's potential by providing a basic nitrogen that can form hydrogen bonds or participate in salt bridge interactions with acidic residues on protein targets.

Recent advancements in computational chemistry have enabled researchers to predict the binding modes and affinities of small molecules like 1-Piperidinyloxy, 4-(dimethylamino)-2,2,6,6-tetramethyl with high precision. These computational studies have suggested that this compound may have significant activity against targets such as kinases and G protein-coupled receptors (GPCRs), which are key players in many disease pathways. For instance, preliminary docking studies have indicated that this molecule could bind to the ATP-binding pocket of certain kinases with high affinity, potentially leading to the development of novel kinase inhibitors.

The stability provided by the tetramethyl group also makes this compound an excellent candidate for long-term storage and transportation without degradation. This is particularly important in pharmaceutical research where maintaining the integrity of compounds over time is crucial for consistent experimental results. Additionally, the compound's solubility profile allows it to be easily formulated into various types of solutions for different types of biological assays.

Another area where this compound shows promise is in the field of medicinal chemistry. The ability to modify different parts of its structure while retaining its core pharmacophoric elements allows researchers to fine-tune its biological activity. For example, replacing one of the methyl groups on the tetramethyl-substituted carbon with another functional group could alter its interactions with biological targets without significantly affecting its overall stability or solubility.

Current research is also exploring the potential applications of this compound in therapeutic contexts beyond traditional drug development. For instance, its structural features make it a suitable candidate for use as an intermediate in the synthesis of more complex molecules that could have applications in regenerative medicine or as probes for studying protein-protein interactions. The versatility of 1-Piperidinyloxy, 4-(dimethylamino)-2,2,6,6-tetramethyl lies in its ability to be functionalized in multiple ways while still maintaining its core biological activity.

In conclusion,1-Piperidinyloxy, 4-(dimethylamino)- 2, 2, 6, 6-tetramethyl (CAS No. 71335-68-7) represents a promising molecule with significant potential in chemical biology and pharmaceutical research. Its unique structural features make it an excellent candidate for further exploration as a scaffold for drug development or as an intermediate in synthetic chemistry. As research continues to uncover new applications for this compound, it is likely that it will play an increasingly important role in advancing our understanding of biological processes and developing new therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)